Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Classical hematology 1CNS 1

Conditions

Lymphoma 16Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myeloid, Acute 6Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Small Cell Lung Carcinoma 4Neuroblastoma 4Burkitt Lymphoma 4Testicular Neoplasms 3Sarcoma 3Lymphoma, T-Cell 3Leukemia 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Waldenstrom Macroglobulinemia 2Testicular Germ Cell Tumor 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Neoplasms, Germ Cell and Embryonal 2Myelodysplastic Syndromes 2Multiple Myeloma 2

Interventions

Rituximab 8Cyclophosphamide 8Peripheral Blood Stem Cell Transplantation 7Methotrexate 7fludarabine phosphate 6Whole-Body Irradiation 5Tacrolimus 5Mycophenolic Acid 5Dexamethasone 5Cyclosporine 5Cytarabine 4Transplantation 3Radiotherapy 3Filgrastim 3Busulfan 3pegfilgrastim 2merphos 2etoposide phosphate 2Methylprednisolone 2Lenalidomide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Carboplatin 2Calcium Dobesilate 2Antilymphocyte Serum 2zanubrutinib 1sodium thiosulfate 1sargramostim 1oblimersen 1ibrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Intraocular Lymphoma × etoposide phosphate × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed
22 enrolled
Lymphoid

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡